New hope for advanced colorectal cancer: experimental combo enters phase 2 trial
NCT ID NCT06948448
First seen Jan 06, 2026 · Last updated Apr 25, 2026 · Updated 21 times
Summary
This study tests whether adding an experimental drug (ONO-4578) to standard chemotherapy and immunotherapy can shrink tumors better than standard care alone in people with a specific type of advanced colorectal cancer. About 144 adults whose cancer has spread and who have not had prior treatment will participate. The goal is to find a more effective first-line option for this hard-to-treat cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Baylor Scott & White Medical Center
RECRUITINGTemple, Texas, 76508, United States
-
Blue Ridge Cancer Care
RECRUITINGSalem, Virginia, 24153, United States
-
CHU Besançon - Hôpital Jean Minjoz
RECRUITINGBesançon, Doubs, France
-
CHU Bordeaux - Hôpital Haut-Lévêque
RECRUITINGPessac, Gironde, France
-
CHU Poitiers - Hôpital la Milétrie
RECRUITINGPoitiers, Vienne, France
-
Centre Leon Berard
RECRUITINGLyon, Rhone, France
-
Chru De Nantes Hotel-Dieu
RECRUITINGNantes, Loire Atlantique, France
-
Hospital General Universitario de Valencia
RECRUITINGValencia, Valencia, Spain
-
Hospital Universitario 12 de Octubre
RECRUITINGMadrid, Madrid, Spain
-
Hospital Universitario Reina Sofia
RECRUITINGCórdoba, Córdoba, Spain
-
Hospital Universitario Virgen del Rocio
RECRUITINGSeville, Sevilla, Spain
-
Hôpital Européen Georges Pompidou
RECRUITINGParis, Paris, France
-
Hôpital Saint-Antoine
RECRUITINGParis, Paris, France
-
Hôpital de la Timone
RECRUITINGMarseille, Marseille, France
-
Istituto Clinico Humanitas
RECRUITINGMilan, Italy, Italy
-
Istituto Europeo di Oncologia
RECRUITINGMilan, Italy, Italy
-
Kobe City Medical Center General Hospital
RECRUITINGHyōgo, Kobe-shi, Japan
-
Mayo Clinic Arizona
RECRUITINGPhoenix, Arizona, 85054, United States
-
Mayo Clinic Florida
RECRUITINGJacksonville, Florida, 32224, United States
-
National Hospital Organization Osaka National Hospital
RECRUITINGOsaka, Osaka-shi, Japan
-
Osaka General Medical Center
RECRUITINGOsaka, Osaka-shi, Japan
-
Osaka International Cancer Institute
RECRUITINGOsaka, Osaka-shi, Japan
-
Princess Margaret Cancer Centre- University Health Network
RECRUITINGToronto, Ontario, M5G 2M9, Canada
-
Rocky Mountain Cancer Centers, LLP
RECRUITINGLone Tree, Colorado, 80124, United States
-
The Ohio State University Comprehensive Cancer Center
RECRUITINGColumbus, Ohio, 43221, United States
-
Thomas Jefferson University, Sidney Kimmel Cancer Center
RECRUITINGPhiladelphia, Pennsylvania, 19107, United States
-
USC Norris Comprehensive Cancer Center
RECRUITINGLos Angeles, California, 90033, United States
-
Virginia Oncology Associates
RECRUITINGNorfolk, Virginia, 23502, United States
Conditions
Explore the condition pages connected to this study.